Dallas, TX, United States of America

Jonathan K Watts


 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jonathan K Watts

Introduction

Jonathan K Watts is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotide duplexes. With a total of 2 patents, his work has implications for gene expression and silencing technologies.

Latest Patents

Watts' latest patents focus on oligonucleotide duplexes comprising DNA-like and RNA-like nucleotides. These novel oligonucleotide pairs can form a duplex that includes one or more DNA-like nucleotides, such as 2'-substituted arabinonucleotides (ANA), in combination with RNA-like nucleotides, including 2'-substituted ribonucleotides (RNA) and locked nucleic acid nucleotides (LNA). The applications of these duplexes are particularly relevant for silencing the expression of specific nucleic acids or genes of interest using small interfering RNA (siRNA) technologies.

Career Highlights

Jonathan K Watts is currently associated with Paladin Labs Inc., where he continues to innovate in the field of biotechnology. His work has garnered attention for its potential applications in therapeutic interventions and genetic research.

Collaborations

Watts has collaborated with esteemed colleagues such as Masad Jose Damha and Glen Deleavey, contributing to the advancement of research in oligonucleotide technologies.

Conclusion

Jonathan K Watts exemplifies the spirit of innovation in biotechnology through his patents and collaborative efforts. His contributions are paving the way for advancements in gene silencing and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…